Can-Fite BioPharma (CANF) Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Can-Fite BioPharma, Ltd. announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80.